Todos os posts

Revisão | Falha no diagnóstico de cirrose no ambiente hospitalar.

29 Ago, 2022 | 13:45h

Missed diagnosis of cirrhosis in the inpatient setting – Journal of Hospital Medicine

 

---

Estudo randomizado | Tratamento com mepolizumabe interrompido vs. continuado por longo prazo na asma eosinofílica grave.

29 Ago, 2022 | 13:44h

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study) – European Respiratory Journal

Comentário: Exacerbations Increased After Discontinuing Long-term Use of Mepolizumab for Severe Eosinophilic Asthma – Consultant 360

 

Comentário no Twitter

This randomised study demonstrates increased exacerbation risk and a decrease in asthma control in patients with severe eosinophilic asthma who stop mepolizumab treatment after long-term use, when compared with those who continue treatment. https://t.co/HYCH0TsU9E pic.twitter.com/rW6hmHgJlj

— ERS publications (@ERSpublications) January 6, 2022

 

---

Estudo de coorte | Pacientes com estenose aórtica bicúspide são mais jovens, tem pior função ventricular esquerda perioperatória e risco aumentado de insuficiência cardíaca pós-operatória em comparação a pacientes com estenose aórtica tricúspide.

29 Ago, 2022 | 13:43h

Patients With Bicuspid Aortic Stenosis Demonstrate Adverse Left Ventricular Remodeling and Impaired Cardiac Function Before Surgery With Increased Risk of Postoperative Heart Failure – Circulation

 

---

Estudo de braço único fase 2 | Quimioterapia neoadjuvante, excisão e observação para câncer retal não avançado.

29 Ago, 2022 | 13:42h

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results – Journal of Clinical Oncology

 

Comentário do autor no Twitter (fio – clique para saber mais)

Pleased to share our ⁦@CDNCancerTrials⁩ NEO Trial results: 79% of patients with cT1-3bN0 #rectalcancer had organ sparing therapy with 3 mo of FOLFOX/CAPOX and transanal surgery. ⁦@drcarl_vancouvr⁩ ⁦@JCO_ASCO⁩ ⁦⁦⁦@OncoAlert⁩ https://t.co/gfcywHk7Y0

— Hagen Kennecke (@HKennecke) August 18, 2022

 

---

Recomendações de consenso | Padronização da avaliação patológica do carcinoma mamário após quimioterapia neoadjuvante.

29 Ago, 2022 | 13:41h

Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy: Recommendations From the I-SPY Pathology Working Group – Archives of Pathology & Laboratory Medicine

 

---

Lesões de células mamárias fusiformes: algoritmo diagnóstico.

29 Ago, 2022 | 13:40h

Spindle Cell Lesions of the Breast: A Diagnostic Algorithm – Archives of Pathology & Laboratory Medicine

 

---

Revisão | Reações à transfusão sanguínea.

29 Ago, 2022 | 13:38h

Blood Transfusion Reactions—A Comprehensive Review of the Literature including a Swiss Perspective – Journal of Clinical Medicine

 

---

Revisão | Regimes medicamentosos de novos antibióticos em pacientes críticos com funções renais variadas.

29 Ago, 2022 | 13:37h

Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review – Antibiotics

 

---

Revisão | Função de culturas de dreno abdominal no tratamento de infecções abdominais.

29 Ago, 2022 | 13:36h

The Role of Abdominal Drain Cultures in Managing Abdominal Infections – Antibiotics

 

---

OMS faz novas recomendações para tratamentos contra Ebola e apela para melhora no acesso a eles.

23 Ago, 2022 | 17:22h

Comunicado de imprensa: WHO makes new recommendations for Ebola treatments, calls for improved access – World Health Organization

Diretriz: Therapeutics for Ebola virus disease – World Health Organization

Comentário: WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries – Health Policy Watch

 

Comentário no Twitter (fio – clique para saber mais)

WHO publishes its first guideline for #Ebola virus disease therapeutics: recommends the use of two monoclonal antibodies.

WHO calls on the global community to increase access to these lifesaving medicines.

📌 https://t.co/tstO3pBYlf pic.twitter.com/ZrDg43TyL2

— World Health Organization (WHO) (@WHO) August 19, 2022

 

---